Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $288.50 -1.65%
Revenue Growth %: -4.3%
Financial Fact:
Net income: 38.03M
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: -4.3%
Financial Fact:
Net income: 38.03M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $995.8 million versus the consensus estimate of $978.34 million.
GUIDANCE:
Charles River Laboratories sees FY 2026 EPS of $10.80-$11.30, versus the consensus of $11.07.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- Canaccord Starts Kistos Holdings (KIST:LN) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
